Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK

Screening for the metabolic side effects of antipsychotic medication: findings of a 6-year quality improvement programme in the UK

Author: BMJ Open

An audit-based, quality improvement programme (QIP) with customised feedback to participating adult, assertive outreach, community psychiatric services in the UK between 2006 and 2012. After each audit, including benchmarked data on their relative and absolute performance against an evidence-based practice standard and the provision of bespoke change interventions. Findings suggest that audit-based QIPs can help improve clinical practice in relation to physical healthcare screening. Nevertheless, they also reveal that only a minority of community psychiatric patients prescribed antipsychotic medication is screened for the metabolic syndrome in accordance with best practice recommendations.

Cookie Settings